Fetal outcome of placenta accreta spectrum disorder patients admitted at Cumilla medical college hospital

Jannath Parvin; Mohammed Kamal Hossain

doi:10.18203/2320-1770.ijrcog20234072

Authors

Jannath Parvin Department of Gynecology and Obstetrics, Mugda Medical College Hospital, Dhaka, Bangladesh
Mohammed Kamal Hossain Department of Gynecology and Obstetrics, Cumilla Medical College, Cumilla, Bangladesh

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20234072

Keywords:

Placenta, PASD, Fetal, Disorder, Obstetrics

Abstract

Background: Placenta accreta spectrum disorder (PASD) is a complex obstetric condition associated with significant maternal and fetal morbidity and mortality. Despite its increasing global prevalence, there is limited research focusing on the fetal outcomes of PASD patients, particularly in Asian populations

Methods: This observational study was conducted at Cumilla medical college hospital over 18 months, starting from January 2022. A total of 60 patients diagnosed with PASD were included, following specific inclusion and exclusion criteria. Data were collected on sociodemographic characteristics, antenatal care, presenting complaints, and fetal outcomes.

Result: The study found that 90% of the participants had live births, while 10% experienced intrauterine death. Among the live births, there was a nearly equal distribution between low and normal birth weights. The sociodemographic distribution was diverse, with the majority of participants falling within the age range of 21-30 years. Half of the participants received regular antenatal care, and antepartum hemorrhage was the most common presenting complaint.

Conclusions: The study provides valuable insights into the fetal outcomes of PASD patients, with a notably high rate of live births. The findings also highlight the importance of regular antenatal care and early diagnosis in managing PASD effectively. The study serves as a foundation for future research aimed at improving both maternal and fetal outcomes in PASD.

Metrics

Metrics Loading ...

References

Thiravit S, Ma K, Goldman I, Pharuhas C, Priyanka J, Daniel SH et al. Role of Ultrasound and MRI in Diagnosis of Severe Placenta Accreta Spectrum Disorder: An Intraindividual Assessment with Emphasis on Placental Bulge. AJR Am J Roentgenol. 2021;217(6):1377-88.

D’Antonio F, Timor-Tritsch IE, Khalil A, Calì G. New classification of placenta accreta spectrum disorders should include presence of Cesarean scar pregnancy. Ultrasound Obstet Gynecol. 2022;59(4):563.

Padilla CR, Shamshirsaz AA, Easter SR, Phillip H, Carly S, Nadir El S et al. Critical Care in Placenta Accreta Spectrum Disorders-A Call to Action. Am J Perinatol. 2023;40(9):988-95.

Morlando M, Collins S. Placenta Accreta Spectrum Disorders: Challenges, Risks, and Management Strategies. Int J Womens Health. 2020;12:1033-45.

Berhan Y, Urgie T. A Literature Review of Placenta Accreta Spectrum Disorder: The Place of Expectant Management in Ethiopian Setup. Ethiop J Health Sci. 2020;30(2):277-92.

Panaitescu AM, Ciobanu AM, Gică N, Peltecu G, Botezatu R. Diagnosis and Management of Cesarean Scar Pregnancy and Placenta Accreta Spectrum: Case Series and Review of the Literature. J Ultrasound Med. 2021;40(9):1975-86.

Wagner W, Loichinger M, Sidebottom AC, Whitney LW, Marc V, Theresa J et al. Implementation and Outcomes of a Model of Care for Placenta Accreta Spectrum in a Community-Based Private Practice. Am J Perinatol. 2022.

Holmes VJ, Skinner S, Silagy M, Rolnik DL, Mol BW, Kroushev A. Changes in practice and management of placenta accreta spectrum disorder: A 20-year retrospective cohort study. Aust N Z J Obstet Gynaecol. 2023;63(6):786-91.

Sai Sri Neeraja S, Amulya CBU. Observational study on placenta accreta spectrum disorders in a tertiary centre for two years. IJAR. 2022;10(12):1329-35.

Ayalde J, Epee-Bekima M, Jansen B. A review of placenta accreta spectrum and its outcomes for perinatal mental health. Aus Psychiatr. 2023;31(1):73-5.

Wijesinghe V, Rishard M, Srisanjeevan S. Quality of surgical management of placenta accreta spectrum in a tertiary center in Sri Lanka: baseline study for quality improvement project: problems and solutions. BMC Pregnancy Childbirth. 2022;22(1):509.

Milla H, Akhmadi SKY, Wibisono F, Sari FR. Risk factors, Diagnosis and Outcomes of Management Strategies of Placenta Accreta Spectrum (PAS) Disorders in Low-resources Settings: Case Report. Int J Human Heal Sci. 2021;5(4):503-9.

Munoz JL, Hernandez B, Curbelo J, Ramsey PS, Ireland KE. Effect of anesthesia selection on neonatal outcomes in cesarean hysterectomies for placenta accreta spectrum (PAS). J Perinat Med. 2022;50(9):1210-14.

Abbas RA, Nassar AH. Placenta Accreta Spectrum: Conservative Management and Its Impact on Future Fertility. Maternal-Fetal Med. 2021;3(4):263.

O’Rinn SE, Barrett JFR, Parsons JA, Kingdom JC, D’Souza R. Engaging pregnant individuals and healthcare professionals in an international mixed methods study to develop a core outcome set for studies on placenta accreta spectrum disorder (COPAS): a study protocol. BMJ Open. 2023;13(4):e060699.

Tadayon M, Javadifar N, Dastoorpoor M, Shahbazian N. Frequency, Risk Factors, and Pregnancy Outcomes in Cases with Placenta Accreta Spectrum Disorder: A Case-Control Study. J Reproduct Infertil. 2022;23(4):279.

Hessami K, Salmanian B, Einerson BD, Daniela AC, Amir AS, Scott AS et al. Clinical Correlates of Placenta Accreta Spectrum Disorder Depending on the Presence or Absence of Placenta Previa: A Systematic Review and Meta-analysis. Obstet Gynecol. 2022;140(4):599-606.

Yao R, Nguyen HY, Hong L, Martin C, Balli K, Ioffe Y. Impact of a Multidisciplinary Team Approach on the Diagnosis and Management of Placenta Accreta Spectrum Disorder [A228]. Obstetr Gynecol. 2022;139:66S.

Flores-Mendoza H, Chandran AR, Hernandez-Nieto C, Ally M, Lisa A, Rory CW et al. Outcomes in emergency versus electively scheduled cases of placenta accreta spectrum disorder managed by cesarean-hysterectomy within a multidisciplinary care team. Int J Gynaecol Obstet. 2022;159(2):404-11.

Placental Growth Factor-soluble FMS-like Tyrosine Kinase-1 Ratio in Placenta Accreta Spectrum Disorder: Case Control Study. Open Access Macedonian J Med Sci. 2023;10(B):848-52.

Han X, Guo Z, Yang X, Yang H, Ma J. Association of Placenta Previa with Severe Maternal Morbidity Among Patients With Placenta Accreta Spectrum Disorder. JAMA Netw Open. 2022;5(8):e2228002.

Umeh UA, Eleje GU, Onuh JU, Ogochukwu TN, Ijeoma VE, Leonard OA et al. Comparison of Placenta Previa and Placenta Accreta Spectrum Disorder Following Previous Cesarean Section between Women with a Short and Normal Interpregnancy Interval. Obstet Gynecol Int. 2022;2022:8028639.